What is cancer chemotherapy?

被引:99
作者
Nygren, P [1 ]
机构
[1] Univ Uppsala Hosp, Sect Oncol, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden
关键词
D O I
10.1080/02841860151116204
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The importance of chemotherapy for cure of cancer is increasing, especially with its use as adjuvans to local therapy. Furthermore in advanced disease, when the tumour has disseminated from its place of origin, chemotherapy has an expanding role in efforts to relieve cancer-related symptoms and to prolong life. Despite ifs shortcomings, chemotherapy, therefore, is an important treatment modality in oncology and will probably remain so for considerable time. This presentation, within the frame of The Swedish Council on Technology Assessment in Health Care (SBU) project to review cancer chemotherapy, aims to provide a brief overview of the field cancer chemotherapy. It includes a historical perspective of cancer chemotherapy, some practical aspects and theoretical considerations with respect to the action of, resistance to and metabolism of these drugs. Furthermore, some outlooks into the nearest future with respect to ways to improve and develop cancer chemotherapy are provided as well as some aspects of chemotherapy From an employee-protection perspective.
引用
收藏
页码:166 / 174
页数:9
相关论文
共 45 条
[1]  
*ARB, 1984, ARB FORF CYT
[2]   BONE-MARROW TRANSPLANTATION [J].
ARMITAGE, JO .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (12) :827-838
[3]  
Beck William T., 1997, P498
[4]   THE CELL BIOLOGY OF MULTIPLE-DRUG RESISTANCE [J].
BECK, WT .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (18) :2879-2887
[5]   DEVELOPMENT OF VINCRISTINE RESISTANCE AND INCREASED SENSITIVITY TO CYCLOSPORINE-A AND VERAPAMIL IN THE HUMAN U-937 LYMPHOMA CELL-LINE WITHOUT OVEREXPRESSION OF THE 170-KDA P-GLYCOPROTEIN [J].
BOTLING, J ;
LIMINGA, G ;
LARSSON, R ;
NYGREN, P ;
NILSSON, K .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) :269-274
[6]  
Boyd M. R., 1993, CURRENT THERAPY ONCO, P11
[7]  
CAVALLINSTAHL E, 1992, CYTOSTATIKUMANUAL 19
[8]  
Cheson Bruce D., 1997, P490
[9]  
COLE SP, 1991, CANCER RES, V51, P689
[10]  
Connors TA, 1996, ANN ONCOL, V7, P445